Treatment of Borderline Personality Disorder: Is Supply Adequate to Meet Public Health Needs?
- PMID: 31138059
- DOI: 10.1176/appi.ps.201900073
Treatment of Borderline Personality Disorder: Is Supply Adequate to Meet Public Health Needs?
Abstract
Objectives: This study aimed to assess the supply of and demand for treatment of borderline personality disorder (BPD) to inform current standards of care and training in the context of available resources worldwide.
Methods: The total supply of mental health professionals and mental health professionals certified in specialist evidence-based treatments for BPD was estimated for 22 countries by using data from publicly available sources and training programs. BPD prevalence and treatment-seeking rates were drawn from large-scale national epidemiological studies. Ratios of treatment-seeking patients to available providers were computed to assess whether current systems are able to meet demand. Training and certification requirements were summarized.
Results: The ratio of treatment-seeking patients with BPD to mental health professionals (irrespective of professionals' interest or training in treating BPD) ranged from approximately 4:1 in Australia, the Netherlands, and Norway to 192:1 in Singapore. The ratio of treatment-seeking patients to clinicians certified in providing evidence-based care ranged from 49:1 in Norway to 148,215:1 in Mexico. Certification requirements differed by treatment and by country.
Conclusions: Shortages of both providers available to treat BPD and providers certified in specialist treatments of BPD exist in most of the 22 countries studied. In well-resourced countries, training clinicians to provide generalist or abbreviated treatments for BPD, in addition to specialist treatments, could help address the current implementation gap. More resource-efficient alternatives must be considered in countries with insufficient staff to implement even generalist treatments. Consideration of realistic allocation of care may shape future guidelines and standards of BPD treatments, beyond intensive evidence-based psychotherapies.
Keywords: Access to care; Borderline personality disorder; Evidence-based treatments; Generalist treatments; Implementation; Training requirements.
Comment in
-
A Dialectical Tension in Health Services.Psychiatr Serv. 2019 Sep 1;70(9):749. doi: 10.1176/appi.ps.70902. Psychiatr Serv. 2019. PMID: 31474218 No abstract available.
-
Advance Directives: Another Gap in Services for People With Borderline Personality Disorder.Psychiatr Serv. 2020 May 1;71(5):529-530. doi: 10.1176/appi.ps.71504. Psychiatr Serv. 2020. PMID: 32354308 No abstract available.
-
Advance Directives: Another Gap in Services for People With Borderline Personality Disorder.Psychiatr Serv. 2020 May 1;71(5):528-529. doi: 10.1176/appi.ps.71402. Psychiatr Serv. 2020. PMID: 32354310 No abstract available.
Similar articles
-
Qualitative Analysis of Resources and Barriers Related to Treatment of Borderline Personality Disorder in the United States.Psychiatr Serv. 2017 Feb 1;68(2):167-172. doi: 10.1176/appi.ps.201600108. Epub 2016 Oct 3. Psychiatr Serv. 2017. PMID: 27691382 Free PMC article.
-
Experiences of care by Australians with a diagnosis of borderline personality disorder.J Psychiatr Ment Health Nurs. 2015 Sep;22(7):510-21. doi: 10.1111/jpm.12226. Epub 2015 Jun 30. J Psychiatr Ment Health Nurs. 2015. PMID: 26122817 Free PMC article.
-
[Mental health service utilization among borderline personality disorder patients inpatient].Encephale. 2015 Apr;41(2):115-22. doi: 10.1016/j.encep.2014.10.008. Epub 2014 Dec 17. Encephale. 2015. PMID: 25526809 French.
-
Evidence-Based Treatments for Borderline Personality Disorder: Implementation, Integration, and Stepped Care.Harv Rev Psychiatry. 2016 Sep-Oct;24(5):342-56. doi: 10.1097/HRP.0000000000000113. Harv Rev Psychiatry. 2016. PMID: 27603742 Review.
-
Cost-effectiveness and Budget Impact of Specialized Psychotherapy for Borderline Personality Disorder: A Synthesis of the Evidence.J Ment Health Policy Econ. 2017 Dec 1;20(4):177-190. J Ment Health Policy Econ. 2017. PMID: 29300704 Review.
Cited by
-
How to Mitigate Risk in the Treatment of Patients with Borderline Personality Disorder.Curr Psychiatry Rep. 2024 Dec;26(12):816-821. doi: 10.1007/s11920-024-01558-5. Epub 2024 Dec 3. Curr Psychiatry Rep. 2024. PMID: 39625602 Review.
-
Structural stigma and its impact on healthcare for borderline personality disorder: a scoping review.Int J Ment Health Syst. 2022 Sep 29;16(1):48. doi: 10.1186/s13033-022-00558-3. Int J Ment Health Syst. 2022. PMID: 36175958 Free PMC article.
-
Online psychoeducation and digital assessments as a first step of treatment for borderline personality disorder: A protocol for a pilot randomized controlled trial.PLoS One. 2023 Dec 7;18(12):e0294331. doi: 10.1371/journal.pone.0294331. eCollection 2023. PLoS One. 2023. PMID: 38060545 Free PMC article.
-
Psychotherapies in opioid use disorder: toward a step-care model.J Neural Transm (Vienna). 2024 May;131(5):437-452. doi: 10.1007/s00702-023-02720-8. Epub 2023 Nov 21. J Neural Transm (Vienna). 2024. PMID: 37987829 Free PMC article. Review.
-
Biofeedback and Treatment for Borderline Personality Disorder.Focus (Am Psychiatr Publ). 2023 Jan;21(1):63-69. doi: 10.1176/appi.focus.20220070. Epub 2023 Jan 16. Focus (Am Psychiatr Publ). 2023. PMID: 37205031 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous